Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation

in nasal polyps and skin. These results indicate that MCs display distinct inflammation-associated effector programs and suggest that in situ MC proliferation is a major component of MC hyperplasia in human T2 inflammation.